StockData

Aspen Neuroscience, Inc. (ASPE) company profile

ASPENasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.00−0.23 (-1.88%)

Close on Nov 17, 2026Market cap –P/E –Yield –

About Aspen Neuroscience

Pharmaceutical Preparations, SIC 2834

Aspen Neuroscience, Inc. is listed on Nasdaq under the ticker ASPE, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31.

Company profile

Company

Legal name
Aspen Neuroscience, Inc.
Headquarters
San Diego, CA
Address
10835 Road To The Cure, Suite 100 92121
Phone
(858) 263-1222
Industry
Pharmaceutical Preparations
Incorporated in
Delaware
Fiscal year ends
December 31

Stock & identifiers

Ticker
ASPE
Exchange
Nasdaq
IPO date
Oct 30, 2026
Filer category
<br>Emerging growth company
SEC CIK
2124080
CUSIP
044933109
ISIN
US0449331091
FIGI
BBG00PK9THH5
Share class FIGI
BBG00PK9THJ3
EIN
83-1312969

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Faheem HasnainExecutive Chair, Director384,679
Damien McDevittSee Remarks, Director561,648
Dalen MeeterChief Financial Officer–
Lisa Johnson-PrattChief Commercial Officer–
Kim RaineriChief Technology Officer–
Jeffrey Lee BoernekeGeneral Counsel and Secretary–
Capital GP VII LLC OrbiMedDirector–
Peter A. ThompsonDirector3,589,132
Advisors Llc OrbimedDirector3,589,132
Andrew SpaventaDirector308,076
Thomas O. DanielDirector–
Caryn PetersonDirector–
Cynthia Dorothy PerettieDirector–
Douglas Carl FisherDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Oct 30, 2026
Offer price
$15.00
Securities offered
9,375,000
Gross proceeds
$140.63M
Exchange
Nasdaq
Lock-up ends (est.)
Apr 28, 2027

“The initial public offering price is $15.00 per share .”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?